In T2DM, in acute conditions, such as acute MI, stroke, or congestive heart failure, insulin is the main indicated treatment; otherwise, the recommended therapeutic approach includes antidiabetic non-insulin drugs. The gene discussed is INS; the disease is stroke disorder.